Your browser doesn't support javascript.
loading
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Chiara Fallerini; Nicola Picchiotti; Margherita Baldassarri; Kristina Zguro; Sergio Daga; Francesca Fava; Elisa Benetti; Sara Amitrano; Mirella Bruttini; Maria Palmieri; Susanna Croci; Mirjam Lista; Giada Beligni; Floriana Valentino; Ilaria Meloni; Marco Tanfoni; Francesca Colombo; Enrico Cabri; Maddalena Fratelli; Chiara Gabbi; Stefania Mantovani; Elisa Frullanti; Marco Gori; Francis P Crawley; Guillaume Butler-Laporte; Brent Richards; Hugo Zeberg; Miklos Lipcsey; Michael Hultstrom; Kerstin U Ludwig; Eva C. Schulte; Erola Pairo-Castineira; John Kenneth Baillie; Axel Schmidt; Robert Frithiof; - WES/WGS working group within the HGI; - GenOMICC Consortium; - GEN-COVID Multicenter Study; Francesca Mari; Alessandra Renieri; Simone Furini.
Affiliation
  • Chiara Fallerini; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Nicola Picchiotti; University of Siena, DIISM-SAILAB, Siena, Italy; Department of Mathematics, University of Pavia, Pavia, Italy
  • Margherita Baldassarri; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Kristina Zguro; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy
  • Sergio Daga; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Francesca Fava; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy; 3) Unive
  • Elisa Benetti; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy
  • Sara Amitrano; Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Italy
  • Mirella Bruttini; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy; 5) Gene
  • Maria Palmieri; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Susanna Croci; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Mirjam Lista; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Giada Beligni; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Floriana Valentino; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Ilaria Meloni; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Marco Tanfoni; University of Siena, DIISM-SAILAB, Siena, Italy
  • Francesca Colombo; Istituto di Tecnologie Biomediche, Consiglio Nazionale delle Ricerche, Segrate (MI), Ital
  • Enrico Cabri; Pharmacogenomics Unit, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Maddalena Fratelli; Pharmacogenomics Unit, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Chiara Gabbi; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
  • Stefania Mantovani; Department of Medicine, Clinical Immunology and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
  • Elisa Frullanti; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy
  • Marco Gori; University of Siena, DIISM SAILAB, Siena, Italy; Models and Algorithms for Artificial Intelligence MAASAI Research Group, Universite Cote d Azur, Inria, CNRS, I
  • Francis P Crawley; Good Clinical Practice Alliance-Europe GCPA and Strategic Initiative for Developing, Capacity in Ethical Review-Europe SIDCER, Brussels, Belgium.
  • Guillaume Butler-Laporte; Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, M
  • Brent Richards; Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, C
  • Hugo Zeberg; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
  • Miklos Lipcsey; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Hedenstierna Laboratory, CIRRUS, Anaesthesiol
  • Michael Hultstrom; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Integrative Physiology, Department of Medical
  • Kerstin U Ludwig; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
  • Eva C. Schulte; Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, 80336, Germany; Department of Psychiatry and Psychotherapy, Uni
  • Erola Pairo-Castineira; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK; Ro
  • John Kenneth Baillie; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK; Ro
  • Axel Schmidt; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany
  • Robert Frithiof; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • - WES/WGS working group within the HGI; -
  • - GenOMICC Consortium; -
  • - GEN-COVID Multicenter Study; -
  • Francesca Mari; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy; Genetica
  • Alessandra Renieri; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy; Medical Genetics, University of Siena, Italy; Genetica
  • Simone Furini; Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Italy
Preprint in English | medRxiv | ID: ppmedrxiv-21262611
Journal article
A scientific journal published article is available and is probably based on this preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See journal article
ABSTRACT
The combined impact of common and rare exonic variants in COVID-19 host genetics is currently insufficiently understood. Here, common and rare variants from whole exome sequencing data of about 4,000 SARS-CoV-2-positive individuals were used to define an interpretable machine learning model for predicting COVID-19 severity. Firstly, variants were converted into separate sets of Boolean features, depending on the absence or the presence of variants in each gene. An ensemble of LASSO logistic regression models was used to identify the most informative Boolean features with respect to the genetic bases of severity. The Boolean features selected by these logistic models were combined into an Integrated PolyGenic Score that offers a synthetic and interpretable index for describing the contribution of host genetics in COVID-19 severity, as demonstrated through testing in several independent cohorts. Selected features belong to ultra-rare, rare, low-frequency, and common variants, including those in linkage disequilibrium with known GWAS loci. Noteworthly, around one quarter of the selected genes are sex-specific. Pathway analysis of the selected genes associated with COVID-19 severity reflected the multi-organ nature of the disease. The proposed model might provide useful information for developing diagnostics and therapeutics, while also being able to guide bedside disease management.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Cohort_studies / Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Cohort_studies / Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
...